People

Will McEwan

Will McEwan

William (Will) McEwan is an academic co-founder and chief scientific adviser at TRIMTECH. He leads a UK Dementia Research Institute group at Cambridge exploring antiviral mechanisms and protein aggregation in neurodegenerative disease. The company identifies his research alongside Leo James’s as a foundation for its TRIM21 platform.

Roles

TRIMTECH Therapeutics

Chief Scientific Adviser; Member of SAB and TRIMTECH Co-founder

Current